BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37634374)

  • 21. A Novel Mutation in
    Padmanabha H; Awati AM; Thomas K; K Sarma GR
    Neurol India; 2021; 69(5):1400-1401. PubMed ID: 34747823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Trisomy 20 mosaicism revealed by pigmentary mosaicism of the Ito-type].
    Girard C; Guillot B; Rivier F; Dalla Vale F; Bessis D
    Ann Dermatol Venereol; 2005 Feb; 132(2):151-3. PubMed ID: 15798568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Split hand foot malformation with whorl-like pigmentary pattern: phenotypic expression of somatic mosaicism for the p63 mutation.
    Kosaki R; Naito Y; Torii C; Takahashi T; Nakajima T; Kosaki K
    Am J Med Genet A; 2008 Oct; 146A(19):2574-7. PubMed ID: 18792980
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel neonatal presentation of megalencephaly-polymicrogyria-pigmentary mosaicism syndrome (MPPM) related to MTOR mutation: Report of a case.
    Taylor DL; Wildin RS; Morley KW
    Pediatr Dermatol; 2021 Mar; 38(2):536-537. PubMed ID: 33325571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dohi Memorial Lecture. New aspects of cutaneous mosaicism.
    Happle R
    J Dermatol; 2002 Nov; 29(11):681-92. PubMed ID: 12484429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seven novel mutations of the ADAR gene in Chinese families and sporadic patients with dyschromatosis symmetrica hereditaria (DSH).
    Zhang XJ; He PP; Li M; He CD; Yan KL; Cui Y; Yang S; Zhang KY; Gao M; Chen JJ; Li CR; Jin L; Chen HD; Xu SJ; Huang W
    Hum Mutat; 2004 Jun; 23(6):629-30. PubMed ID: 15146470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terminal osseous dysplasia with pigmentary defects (TODPD) due to a recurrent filamin A (FLNA) mutation.
    Brunetti-Pierri N; Torrado M; Fernandez Mdel C; Tello AM; Arberas CL; Cardinale A; Piccolo P; Bacino CA
    Mol Genet Genomic Med; 2014 Nov; 2(6):467-71. PubMed ID: 25614868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mutations in KMT2B offer pathophysiological insights into childhood-onset progressive dystonia.
    Dafsari HS; Sprute R; Wunderlich G; Daimagüler HS; Karaca E; Contreras A; Becker K; Schulze-Rhonhof M; Kiening K; Karakulak T; Kloss M; Horn A; Pauls A; Nürnberg P; Altmüller J; Thiele H; Assmann B; Koy A; Cirak S
    J Hum Genet; 2019 Aug; 64(8):803-813. PubMed ID: 31165786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postzygotic inactivating mutations of RHOA cause a mosaic neuroectodermal syndrome.
    Vabres P; Sorlin A; Kholmanskikh SS; Demeer B; St-Onge J; Duffourd Y; Kuentz P; Courcet JB; Carmignac V; Garret P; Bessis D; Boute O; Bron A; Captier G; Carmi E; Devauchelle B; Geneviève D; Gondry-Jouet C; Guibaud L; Lafon A; Mathieu-Dramard M; Thevenon J; Dobyns WB; Bernard G; Polubothu S; Faravelli F; Kinsler VA; Thauvin C; Faivre L; Ross ME; Rivière JB
    Nat Genet; 2019 Oct; 51(10):1438-1441. PubMed ID: 31570889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation.
    Groen JL; Ritz K; Contarino MF; van de Warrenburg BP; Aramideh M; Foncke EM; van Hilten JJ; Schuurman PR; Speelman JD; Koelman JH; de Bie RM; Baas F; Tijssen MA
    Mov Disord; 2010 Oct; 25(14):2420-7. PubMed ID: 20687191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pigmentary mosaicism: a review of original literature and recommendations for future handling.
    Kromann AB; Ousager LB; Ali IKM; Aydemir N; Bygum A
    Orphanet J Rare Dis; 2018 Mar; 13(1):39. PubMed ID: 29506540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic Mosaicism of PCDH19 in a male with early infantile epileptic encephalopathy and review of the literature.
    Perez D; Hsieh DT; Rohena L
    Am J Med Genet A; 2017 Jun; 173(6):1625-1630. PubMed ID: 28462982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pigmentary mosaicism, subcortical band heterotopia, and brain cystic lesions.
    Ruggieri M; Roggini M; Spalice A; Addis M; Iannetti P
    Pediatr Neurol; 2009 May; 40(5):383-6. PubMed ID: 19380077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pigmentary mosaicism as a recurrent clinical manifestation in three new patients with mosaic trisomy 12 diagnosed postnatally: cases report and literature review.
    Martínez-Hernández A; Martínez-Anaya D; Durán-McKinster C; Del Castillo-Ruiz V; Navarrete-Meneses P; Córdova EJ; Villegas-Torres BE; Ruiz-Herrera A; Juárez-Velázquez R; Yokoyama-Rebollar E; Cervantes-Barragán D; Pedraza-Meléndez A; Orozco L; Pérez-Vera P; Salas-Labadía C
    BMC Med Genomics; 2022 Oct; 15(1):224. PubMed ID: 36316743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of the first polyalanine tract of the ARX gene in a boy presenting with generalized dystonia in the absence of infantile spasms.
    Shinozaki Y; Osawa M; Sakuma H; Komaki H; Nakagawa E; Sugai K; Sasaki M; Goto Y
    Brain Dev; 2009 Jun; 31(6):469-72. PubMed ID: 18823727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of DYT1 in primary torsion dystonia in Europe.
    Valente EM; Warner TT; Jarman PR; Mathen D; Fletcher NA; Marsden CD; Bhatia KP; Wood NW
    Brain; 1998 Dec; 121 ( Pt 12)():2335-9. PubMed ID: 9874484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrafamilial variability of the primary dystonia DYT6 phenotype caused by p.Cys5Trp mutation in THAP1 gene.
    Jurek M; Hoffman-Zacharska D; Koziorowski D; Mądry J; Friedman A; Bal J
    Neurol Neurochir Pol; 2014; 48(4):254-7. PubMed ID: 25168324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infantile-onset CMT2D/dSMA-V in a Chinese family with parental germline mosaicism for a novel mutation in the GARS1 gene.
    Huang Y; Bi B; Zhao P; Yu T; Luo S; Tan L; Liu Z; Liu J; He X
    Mol Genet Genomic Med; 2022 Jan; 10(1):e1846. PubMed ID: 34898052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities.
    Carmignac V; Mignot C; Blanchard E; Kuentz P; Aubriot-Lorton MH; Parker VER; Sorlin A; Fraitag S; Courcet JB; Duffourd Y; Rodriguez D; Knox RG; Polubothu S; Boland A; Olaso R; Delepine M; Darmency V; Riachi M; Quelin C; Rollier P; Goujon L; Grotto S; Capri Y; Jacquemont ML; Odent S; Amram D; Chevarin M; Vincent-Delorme C; Catteau B; Guibaud L; Arzimanoglou A; Keddar M; Sarret C; Callier P; Bessis D; Geneviève D; Deleuze JF; Thauvin C; Semple RK; Philippe C; Rivière JB; Kinsler VA; Faivre L; Vabres P
    Genet Med; 2021 Aug; 23(8):1484-1491. PubMed ID: 33833411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.